AAAAAA
Results:
1-11
|
Results: 11
Authors:
STEGNAR M
UHRIN P
PETERNEL P
MAVRI A
SALOBIRPAJNIC B
STARE J
BINDER BR
Citation: M. Stegnar et al., THE 4G 5G SEQUENCE POLYMORPHISM IN THE PROMOTER OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) GENE - RELATIONSHIP TO PLASMA PAI-1 LEVEL IN VENOUS THROMBOEMBOLISM/, Thrombosis and haemostasis, 79(5), 1998, pp. 975-979
Authors:
STEGNAR M
PETERNEL P
UHRIN P
CVELBARMARINKO T
GORSICTOMAZIC K
BINDER BR
Citation: M. Stegnar et al., FIBRINOLYSIS IN PATIENTS WITH THE 1691-G-]A MUTATION IN FACTOR-V GENEAND HISTORY OF DEEP-VEIN THROMBOSIS, Fibrinolysis & proteolysis, 11(4), 1997, pp. 201-207
Authors:
BOZIC B
KVEDER T
STEGNAR M
MOROSINIBERUS E
KOSGOLJA M
PETERNEL P
ROZMAN B
Citation: B. Bozic et al., INFLUENCE OF DEGRADED PHOSPHATIDYLSERINE ON BINDING OF ANTIPHOSPHOLIPID ANTIBODIES, International archives of allergy and immunology, 112(1), 1997, pp. 19-26
Authors:
STEGNAR M
UHRIN P
PETERNEL P
MAVRI A
ZEYDA M
SALOBIRPAJNIC B
BINDER BR
Citation: M. Stegnar et al., ASSOCIATION OF THE 4G 5G POLYMORPHISM AND METABOLIC FACTORS TO PLASMAPLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS IN DEEP-VEIN THROMBOSIS/, Thrombosis and haemostasis, 1997, pp. 393-393
Authors:
STEGNAR M
PETERNEL P
UHRIN P
CVELBARMARINKO T
GORSICTOMAZIC K
BINDER BR
Citation: M. Stegnar et al., THE 1691-G-]A MUTATION IN FACTOR-V GENE AND IMPAIRED FIBRINOLYSIS IN PATIENTS WITH HISTORY OF DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 1257-1257
Authors:
PETERNEL P
SALOBIRPAJNIC B
COKAN A
JUVAN K
Citation: P. Peternel et al., ASSOCIATION BETWEEN OVERDOSING OF COUMADIN TREATMENT AND BLEEDING COMPLICATIONS IN PATIENTS OLDER THAN 70 YEARS, Thrombosis and haemostasis, 1997, pp. 2879-2879
Authors:
GRUBIC N
STEGNAR M
PETERNEL P
KAIDER A
BINDER BR
Citation: N. Grubic et al., A NOVEL G A AND THE 4G/5G POLYMORPHISM WITHIN THE PROMOTER OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE IN PATIENTS WITH DEEP-VEIN THROMBOSIS/, Thrombosis research, 84(6), 1996, pp. 431-443
Authors:
SALOBIRPAJNIC B
STEGNAR M
PETERNEL P
OBERSNELKVEDER D
GROBOVSEKOPARA S
Citation: B. Salobirpajnic et al., FIBRINOLYSIS AFTER MYOCARDIAL-INFARCTION AND VENOUS THROMBOEMBOLISM IN WOMEN IN THE REPRODUCTIVE PERIOD, Thrombosis and haemostasis, 73(6), 1995, pp. 1139-1139
Authors:
PETERNEL P
SMUC K
STALC M
MAVRI A
Citation: P. Peternel et al., BLOOD FIBRINOLYTIC-ACTIVITY DURING NORMAL MENSTRUAL-CYCLE IN YOUNG AND IN PREMENOPAUSAL WOMEN, Thrombosis and haemostasis, 73(6), 1995, pp. 1139-1139
Authors:
PETERNEL P
STEGNAR M
MAVRI A
SALOBIRPAJNIC B
Citation: P. Peternel et al., THE EFFECT OF FASTING AND OR BODY-WEIGHT REDUCTION ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1)/, Fibrinolysis, 8, 1994, pp. 41-43
Authors:
PETERNEL P
SALOBIRPAJNIC B
STEGNAR M
Citation: P. Peternel et al., MONITORING OF LONG-TERM ORAL ANTICOAGULANT TREATMENT IN ELDERLY PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 1133-1133
Risultati:
1-11
|